
ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
Episodes

Monday Apr 19, 2021
Pharmacy Leaders: Are Leaders Born or Made?
Monday Apr 19, 2021
Monday Apr 19, 2021
In this episode of the Pharmacy Leaders series podcast, host, Sara White, MS, FASHP, along with Kimberly Boler BS, CPhT, CSPT, DPLA, and Sam Calabrese MBA, FASHP discusses the role of pharmacy technicians as leaders. This podcast explores whether leaders are born or made and the non-negotiable qualities of a successful leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician

Friday Apr 16, 2021
Therapeutic Thursdays: Harm Reduction Strategies
Friday Apr 16, 2021
Friday Apr 16, 2021
Harm reduction is a public health strategy designed to reduce the adverse consequences associated with drug and alcohol use. The goal for providers is to work with individuals to minimize the harmful effects of drug use and to promote safer use in a compassionate, non-judgmental manner. Dr. Courtenay Wilson will discuss evidence-based strategies to reduce harm for individuals that abuse drugs and alcohol.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday Apr 16, 2021
Student Pharmacists on the Team – Medical Student Perspectives
Friday Apr 16, 2021
Friday Apr 16, 2021
Interdisciplinary rounding teams are a common occurrence within health-systems. In this podcast, listeners will hear from a medical resident and a medical student about their experiences on working on an interdisciplinary team and discuss their appreciation for the pharmacy team.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Thursday Apr 15, 2021
Thursday Apr 15, 2021
This podcast series will highlight the recommended approach to managing patients with peripheral arterial disease from screening to therapy selection. Appropriate risk factor modification and therapy is essential in PAD to optimize care by reducing cardiovascular morbidly and mortality.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Wednesday Apr 14, 2021
Instituting a Remote Layered Learning Model: Easy as Cake!
Wednesday Apr 14, 2021
Wednesday Apr 14, 2021
The COVID-19 pandemic has required pharmacist preceptors to rethink how to deliver APPE and resident rotations within our health systems. This podcast will explain a successful model implemented within an ambulatory care setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Monday Apr 12, 2021
Managing Through Pharmacy Service Changes During a Pandemic
Monday Apr 12, 2021
Monday Apr 12, 2021
This podcast will focus on leading through rapid change as a result of Covid-19. The main topics include change within various pharmacy services, including hospital closures, mergers and acquisitions, restructuring pharmacist responsibilities and modification or elimination of current pharmacy services. In addition to discussing changes, this podcast will discuss lessons learned, opportunities that arose and efforts to reactivate services that were discontinued.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday Apr 09, 2021
Friday Apr 09, 2021
Join our content matter experts from the 2020 Midyear Clinical Meeting as they identify optimization strategies for pain and sedation medication management in mechanically ventilated COVID-19 patients, describe the patient-specific considerations when optimizing pain and sedation management affected by drug shortages and discuss patient-specific challenges associated with medication shortages for COVID-19 patients requiring mechanical ventilation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Thursday Apr 08, 2021
Thursday Apr 08, 2021
With the increased use of direct-activity oral anticoagulants (DOACs) over the last decade, it is inevitable that emergency departments are seeing more patients with DOAC-related bleeding. Get an inside look at pharmacists’ strategies for optimizing reversal of DOAC-related bleeding in various ED settings.
To learn more about this initiative, visit www.ashpadvantage.com/stopdoacbleed
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Thursday Apr 08, 2021
Thursday Apr 08, 2021
This podcast series will highlight the recommended approach to managing patients with peripheral arterial disease from screening to therapy selection. Appropriate risk factor modification and therapy is essential in PAD to optimize care by reducing cardiovascular morbidly and mortality.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Monday Apr 05, 2021
Pharmacy Leadership: Managing and Leading From Afar
Monday Apr 05, 2021
Monday Apr 05, 2021
In this episode, Elyse Macdonald shares her experiences and best practices for combining remote work and patient care and how to continually engage staff during the transition from and back to working in person.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
